Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals

被引:20
作者
Dayali, Sanjana
Lentz, Steven R.
机构
[1] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.1089/ars.2007.1806
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperhomocysteinemia is a risk factor for cardiovascular disease, stroke, and thrombosis. Several animal models of hyperhomocysteinemia have been developed by using both dietary and genetic approaches. These animal models have provided considerable insight into the mechanisms underlying the adverse vascular effects of hyperhomocysteinemia. Accumulating evidence suggests a significant role of altered cellular redox reactions in the vascular phenotype of hyperhomocysteinemia. Redox effects of hyperhomocysteinemia are particularly important in mediating the adverse effects of hyperhomocysteinemia on the endothelium, leading to loss of endothelium-derived nitric oxide and vasomotor dysfunction. Redox reactions also may be key factors in the development of vascular hypertrophy, thrombosis, and atherosclerosis in hyperhomocysteinemic animals. In this review, we summarize the metabolic relations between homocysteine and the cellular redox state, the vascular phenotypes that have been observed in hyperhomocysteinemic animals, the evidence for altered redox reactions in vascular tissue, and the specific redox reactions that may mediate the vascular effects of hyperhomocysteinemia.
引用
收藏
页码:1899 / 1909
页数:11
相关论文
共 106 条
[41]   Compensatory mechanisms influence hemostasis in setting of eNOS deficiency [J].
Iafrati, MD ;
Vitseva, O ;
Tanriverdi, K ;
Blair, P ;
Rex, S ;
Chakrabarti, S ;
Varghese, S ;
Freedman, JE .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (04) :H1627-H1632
[42]   Molecular targeting by homocysteine: a mechanism for vascular pathogenesis [J].
Jacobsen, DW ;
Catanescu, O ;
DiBello, PM ;
Barbato, JC .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (10) :1076-1083
[43]   Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation [J].
Jiang, XH ;
Yang, F ;
Tan, HM ;
Liao, D ;
Bryan, RM ;
Randhawa, JK ;
Rumbaut, RE ;
Durante, W ;
Schafer, AI ;
Yang, XF ;
Wang, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) :2515-2521
[44]   Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta - Role for superoxide anions [J].
Lang, D ;
Kredan, MB ;
Moat, SJ ;
Hussain, SA ;
Powell, CA ;
Bellamy, MF ;
Powers, HJ ;
Lewis, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :422-427
[45]   Vascular NAD(P)H oxidases:: specific features, expression, and regulation [J].
Lassègue, B ;
Clempus, RE .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2003, 285 (02) :R277-R297
[46]   Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys [J].
Lentz, SR ;
Malinow, MR ;
Piegors, DJ ;
BhopatkarTeredesai, M ;
Faraci, FM ;
Heistad, DD .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2930-2934
[47]   Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine β-synthase-deficient mice [J].
Lentz, SR ;
Erger, RA ;
Dayal, S ;
Maeda, N ;
Malinow, MR ;
Heistad, DD ;
Faraci, FM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (03) :H970-H975
[48]   Homocysteine: Is it a clinically important cardiovascular risk factor? [J].
Lentz, SR ;
Haynes, WG .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2004, 71 (09) :729-734
[49]   Mechanisms of homocysteine-induced atherothrombosis [J].
Lentz, SR .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) :1646-1654
[50]   Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia [J].
Lentz, SR ;
Sobey, CG ;
Piegors, DJ ;
Bhopatkar, MY ;
Faraci, FM ;
Malinow, MR ;
Heistad, DD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :24-29